Become A Wiser, More Profitable Investor

Supernus Pharmaceuticals Exceeds Expectations and Attracts ... - Best Stocks

investing

On Tuesday, May 9th, Supernus Pharmaceuticals, Inc (NASDAQ:SUPN) reported their quarterly earnings results, delighting analysts and investors alike. The specialty pharmaceutical company exceeded the consensus estimates for their EPS by an impressive $0.17, reporting $0.29 in earnings per share. Polaris Capital Management LLC, a global investment firm with expertise in healthcare and technology investments, has taken note of this promising performance and invested further into the company. According to a recent filing with the Securities and Exchange Commission, Polaris Capital Management LLC has increased its holdings in Supernus Pharmaceuticals by 29.2% during the fourth quarter of 2021.

beststocks.com     May 14, 2023